In this report, we review global InsurTech funding and investment quarter over quarter. We continue our focus for the 2023 series on the lifecycle of InsurTech funding, with this report spotlighting early-stage acceleration [Series A].

Author: Andrew Johnston MA, Ph.D


Since the height of InsurTech investing and valuations, we’re now experiencing a very healthy inflection point focusing on sustainability, which is reflected by a downturn of speculative investment capital. InsurTechs that focus on clear commercial outcomes are gaining more traction than those trying to offer their technology (only) as a product.

Key Findings for Q2

  • Global InsurTech funding fell 34.0% quarter on quarter, from $1.39 billion to $916.71 million.
  • Companies raising capital within the early-stage acceleration category raised $134.49M — or 14.7% of total InsurTech funding.
  • Q2 23 saw 43 corporate InsurTech investments from (re)insurers, of which 34.9% were directed toward US-based InsurTechs — more than any other country.


Author Information